Pharma Co. Hit With Investor Suit Over Freeze Of Drug Study
An investor in Scynexis Inc. hit the pharmaceutical company and its executives with a proposed securities class action on Wednesday, alleging that the company misled shareholders over the approval prospects of...To view the full article, register now.
Already a subscriber? Click here to view full article